Enstar Group Pref Share ESGRO 7.0 Prep 03/01/24 E | 10-Q: FY2025 Q1 Revenue: USD 204 M

Revenue: As of FY2025 Q1, the actual value is USD 204 M.

EPS: As of FY2025 Q1, the actual value is USD 3.32.

EBIT: As of FY2025 Q1, the actual value is USD 55 M.

Run-off Segment

• Revenues: $14 million for the three months ended March 31, 2025.
• Net Incurred Losses and LAE: - $26 million for the three months ended March 31, 2025.
• Defendant Asbestos and Environmental Expenses: - $1 million for the three months ended March 31, 2025.
• Salaries and Benefit Expenses: $28 million for the three months ended March 31, 2025.
• Professional Fee Expenses: $6 million for the three months ended March 31, 2025.
• Other Segment Expenses: $8 million for the three months ended March 31, 2025.
• Segment Net Loss: - $1 million for the three months ended March 31, 2025.

Investments Segment

• Revenues: $189 million for the three months ended March 31, 2025.
• Income from Equity Method Investments: $4 million for the three months ended March 31, 2025.
• Salaries and Benefit Expenses: $5 million for the three months ended March 31, 2025.
• Professional Fee Expenses: $1 million for the three months ended March 31, 2025.
• Other Segment Expenses: $4 million for the three months ended March 31, 2025.
• Segment Net Income: $183 million for the three months ended March 31, 2025.

Corporate and Other

• Other Income: $1 million for the three months ended March 31, 2025.
• Net Incurred Losses and LAE: - $10 million for the three months ended March 31, 2025.
• Defendant Asbestos and Environmental Expenses: - $5 million for the three months ended March 31, 2025.
• Amortization of Net Deferred Charge Assets: - $30 million for the three months ended March 31, 2025.
• General and Administrative Expenses: - $40 million for the three months ended March 31, 2025.
• Interest Expense: - $23 million for the three months ended March 31, 2025.
• Net Foreign Exchange Losses: - $16 million for the three months ended March 31, 2025.
• Dividends on Preferred Shares: - $9 million for the three months ended March 31, 2025.
• Total Corporate and Other Net Loss: - $132 million for the three months ended March 31, 2025.

Outlook

The company anticipates receiving all requisite regulatory approvals for the merger by mid-2025, with the merger expected to close in mid-2025.